| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.8M | +407.7% | +1331.8% |
| Cost of Revenue | $6.4M | +42.8% | +92.4% |
| Gross Profit | -$1.6M | +54.5% | +46.2% |
| R&D Expense | $3.8M | +41.5% | +30.7% |
| SG&A Expense | $3.9M | +7.8% | -49.1% |
| Operating Income | -$9.9M | +2.6% | +28.4% |
| Net Income | -$9.3M | +9.9% | +30.7% |
| EPS (Basic) | -$0.07 | +22.2% | +61.1% |
| EPS (Diluted) | -$0.07 | +22.2% | +61.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.9M | +55.0% | +132.5% |
| Accounts Receivable | $4.2M | +247.2% | +1187.0% |
| Inventory | $285K | +173.4% | -50.4% |
| Current Assets | $63.1M | +51.9% | +106.8% |
| Total Assets | $123.3M | +21.6% | +39.7% |
| Current Liabilities | $4.2M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.9M | -137.4% | — |
| Investing Cash Flow | -$2.2M | -208.9% | — |
| Financing Cash Flow | $55.4M | +110.5% | — |
| -75.7% |
| Long-term Debt | $2.1M | — | — |
| Total Liabilities | $4.4M | -20.3% | -75.3% |
| Stockholders' Equity | $119.0M | +23.9% | +68.5% |